CCL20 and neoplasm: Thus, recombinant Newcastle disease virus expressing the dendritic cell chemokine MIP-3α (iNDV3α-LP) being immobilized on vessel-targeting, iRGD-functionalized liposome carriers induce tumor-specific cellular and humoral immunity, inhibits angiogenesis and suppresses the immunosuppressive tumor microenvironment [126].